Citigroup Inc Emergent Bio Solutions Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Citigroup Inc holds 3,912 shares of EBS stock, worth $39,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,912

Previous 34,189 88.56%

Holding current value

$39,550

Previous $218,000 84.4%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$5.63 - $9.32 $170,459 - $282,181	-30,277 Reduced 88.56%	3,912 $34,000
Q2 2025 Aug 11, 2025	SELL	$4.26 - $6.94 $225,758 - $367,785	-52,995 Reduced 60.79%	34,189 $218,000
Q1 2025 May 12, 2025	BUY	$4.66 - $11.66 $7,758 - $19,413	1,665 Added 1.95%	87,184 $423,000
Q4 2024 Feb 12, 2025	BUY	$7.72 - $11.97 $354,201 - $549,195	45,881 Added 115.75%	85,519 $817,000
Q3 2024 Nov 12, 2024	BUY	$5.72 - $14.77 $101,284 - $261,532	17,707 Added 80.74%	39,638 $330,000

Q2 2024 Aug 12, 2024	BUY	$1.86 - $6.98 $17,789 - $66,756	9,564 Added 77.33%	21,931 $149,000
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $7,174 - $16,310	4,783 Added 63.07%	12,367 $31,000
Q4 2023 Feb 09, 2024	SELL	$1.82 - $3.16 $13,620 - $23,649	-7,484 Reduced 49.67%	7,584 $18,000
Q3 2023 Nov 09, 2023	SELL	$3.17 - $7.91 $567,182 - $1.42 Million	-178,922 Reduced 92.23%	15,068 $51,000
Q2 2023 Aug 10, 2023	SELL	$7.35 - $13.21 $980,262 - $1.76 Million	-133,369 Reduced 40.74%	193,990 $1.43 Million
Q1 2023 May 11, 2023	BUY	$7.79 - $16.29 $922,304 - $1.93 Million	118,396 Added 56.66%	327,359 $3.39 Million
Q4 2022 Feb 09, 2023	SELL	$11.0 - $21.45 $278,938 - $543,929	-25,358 Reduced 10.82%	208,963 $2.47 Million
Q3 2022 Nov 10, 2022	BUY	$20.09 - $35.8 $1.7 Million - $3.03 Million	84,699 Added 56.61%	234,321 $4.92 Million
Q2 2022 Aug 10, 2022	BUY	$27.42 - $43.63 $2.32 Million - $3.69 Million	84,482 Added 129.69%	149,622 $4.64 Million
Q1 2022 May 12, 2022	SELL	$36.48 - $52.22 $2.6 Million - $3.72 Million	-71,189 Reduced 52.22%	65,140 $2.68 Million
Q4 2021 Feb 10, 2022	BUY	$33.11 - $55.01 $3.17 Million - $5.27 Million	95,772 Added 236.14%	136,329 $5.93 Million
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $2.03 Million - $2.68 Million	40,557 New	40,557 $2.03 Million

Others Institutions Holding EBS

# of Institutions

192

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account